Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 154

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 1A
Chunk 154
---
 March 31, 2025, financial statements contain an explanatory paragraph expressing
substantial doubt about our ability to continue as a going concern. The financial statements have been prepared “assuming that
we will continue as a going concern,” which contemplates that we will realize our assets and satisfy our liabilities and commitments
in the ordinary course of business. We have suffered recurring losses from operations, and our working capital is insufficient to fund
our operations for the next 12 months. These factors raise substantial doubt about our ability to continue as a going concern.

RESULTS
OF OPERATION

    For Fiscal Year Ended March 31, 

    2025  
    2024 
  
    Revenues 
    $1,132,533  
    $968,706 
  
    Total Cost of Sales 
     137,677  
     101,823 
  
    Total Operating Expenses 
     9,050,575  
     11,488,223 
  
    Total Other Income (Expense) 
     (343,446) 
     (335,955)
  
    Net Loss 
     (8,399,166) 
     (10,955,295)
  
    Net loss per share - basic and diluted 
    $(.41) 
    $(.78)

For
The Fiscal Year Ended March 31, 2025 (“fiscal 2025”) Compared to The Year Ended March 31, 2024 (“fiscal 2024”)

Total
Revenues. Revenues were $1,132,533 in fiscal 2025 compared to $968,706 for fiscal 2024. Revenues in fiscal 2025 consisted of
sales of our Spryng® product to our Distributors of $956,159 and to veterinary clinics in the amount of $176,374. In fiscal 2024
consisted of sales of our Spryng® product to our Distributors of $731,813 and to veterinary clinics in the amount of $236,893. The
increase in our revenues in the twelve months ended March 31, 2025, is due to sales to our Distributors pursuant to our distribution
partnerships with Vedco and Clipper Distributing and sales of PrecisePRP product pursuant to our Exclusive License Agreement with VetStem.

28

Total
Cost of Sales. Cost of sales was $137,677 in fiscal 2025 compared to $101,823 for fiscal